Page last updated: 2024-08-21

thiazoles and natriuretic peptide, brain

thiazoles has been researched along with natriuretic peptide, brain in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (75.00)	29.6817
2010's	1 (12.50)	24.3611
2020's	1 (12.50)	2.80

Authors

Authors	Studies
Ikeda, U; Lee, RT; Ohki, R; Shimada, K; Yamamoto, K	1
Goto, K; Irukayama-Tomobe, Y; Miyauchi, T; Ogata, T; Sakai, S; Yamaguchi, I	1
Burns, WC; Burrell, LM; Candido, R; Cooper, ME; Dean, RG; Forbes, JM; Ritchie, RH; Thallas, V; Thomas, MC; Tikellis, C; Twigg, SM	1
Kass, DA	1
Ito, S; Ogawa, S; Takeuchi, K	1
Gardner, DG; Liang, F; Wang, F; Zhang, S	1
Chefu, SG; Demchenko, EA; Dmitriev, YV; Dracheva, AV; Galagudza, IM; Karpov, AA; Minasian, SM; Vasina, LV	1
Bang, ML; Frossard, N; Gassmann, M; Nemska, S; Tavakoli, R	1

Trials

1 trial(s) available for thiazoles and natriuretic peptide, brain

Article	Year
Plasma BNP levels in the treatment of type 2 diabetes with pioglitazone. The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:8 Topics: Aged; Atrial Natriuretic Factor; Body Mass Index; Buformin; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Heart Failure; Humans; Hypoglycemic Agents; Male; Middle Aged; Natriuretic Peptide, Brain; Pioglitazone; Stroke Volume; Thiazoles; Thiazolidinediones	2003

Article

Year

Plasma BNP levels in the treatment of type 2 diabetes with pioglitazone.

The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:8

Topics: Aged; Atrial Natriuretic Factor; Body Mass Index; Buformin; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Heart Failure; Humans; Hypoglycemic Agents; Male; Middle Aged; Natriuretic Peptide, Brain; Pioglitazone; Stroke Volume; Thiazoles; Thiazolidinediones

2003

Other Studies

7 other study(ies) available for thiazoles and natriuretic peptide, brain

Article	Year
Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes. Circulation, 2001, Oct-02, Volume: 104, Issue:14 Topics: Angiotensin II; Animals; Animals, Newborn; Biological Transport; Cardiomegaly; Cells, Cultured; Chromans; Heart; Leucine; Myocardium; Natriuretic Peptide, Brain; NF-kappa B; Phenylephrine; Prostaglandin D2; Rats; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Stress, Mechanical; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone	2001
Peroxisome proliferator-activated receptor-gamma activators inhibit endothelin-1-related cardiac hypertrophy in rats. Clinical science (London, England : 1979), 2002, Volume: 103 Suppl 48 Topics: Analysis of Variance; Animals; Cardiomegaly; Chromans; Endothelin-1; Endothelins; Male; Natriuretic Peptide, Brain; Pioglitazone; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stimulation, Chemical; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone	2002
A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes. Circulation research, 2003, Apr-18, Volume: 92, Issue:7 Topics: Animals; Blood Pressure; Body Weight; Collagen; Cytokines; Diabetes Mellitus, Experimental; Gene Expression Regulation; Glycation End Products, Advanced; Heart Ventricles; Hypertrophy, Left Ventricular; Immunohistochemistry; Male; Myocardium; Natriuretic Peptide, Brain; Organ Size; Rats; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Thiazoles	2003
Getting better without AGE: new insights into the diabetic heart. Circulation research, 2003, Apr-18, Volume: 92, Issue:7 Topics: Animals; Collagen; Cytokines; Diabetes Mellitus, Experimental; Gene Expression Regulation; Glycation End Products, Advanced; Heart Ventricles; Hypertrophy, Left Ventricular; Natriuretic Peptide, Brain; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Thiazoles	2003
Peroxisome proliferator activated receptor (PPAR)alpha agonists inhibit hypertrophy of neonatal rat cardiac myocytes. Endocrinology, 2003, Volume: 144, Issue:9 Topics: Animals; Animals, Newborn; Base Sequence; Cell Size; Cells, Cultured; Fenofibrate; Gene Expression; Heart Ventricles; Hypertrophy; Hypoglycemic Agents; Hypolipidemic Agents; Ligands; Molecular Sequence Data; Mutagenesis, Site-Directed; Myocytes, Cardiac; Natriuretic Peptide, Brain; Peroxisome Proliferators; Pyrimidines; Rats; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Sarcomeres; Thiazoles; Thiazolidinediones; Transcription Factors	2003
[CARDIOPROTFETIVE EFECTS OF NECROSTATIN-7 IN THE RAT MODEL OF PERMANENT CORONARY OCCLUSION]. Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova, 2015, Volume: 101, Issue:4 Topics: Animals; Apoptosis; Autophagy; Cicatrix; Coronary Vessels; Disease Models, Animal; Heart Ventricles; Male; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Rats, Wistar; Thiazoles; Ventricular Remodeling	2015
Antagonizing the CX3CR1 Receptor Markedly Reduces Development of Cardiac Hypertrophy After Transverse Aortic Constriction in Mice. Journal of cardiovascular pharmacology, 2021, 12-01, Volume: 78, Issue:6 Topics: Animals; Aorta; Atrial Natriuretic Factor; Chemokine CX3CL1; Collagen Type I, alpha 1 Chain; Constriction; CX3C Chemokine Receptor 1; Disease Models, Animal; Fibrosis; Hypertrophy, Left Ventricular; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Natriuretic Peptide, Brain; Pyrimidines; Signal Transduction; Thiazoles; Time Factors; Transforming Growth Factor beta1; Ventricular Function, Left; Ventricular Remodeling	2021